NVO Competitors & Alternatives
Compare Novo Nordisk A/S with similar stocks in the same industry
Drug Manufacturers - General
NVO
Main Stock$47.09
Tradestie Score
39
Market Cap
$262.92B
P/E Ratio
11.2
Revenue Growth
0.2%
Analyst Upside
+1.6%
Top Competitors
20 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
UNH
UNITEDHEALTH GROUP INCORPORATED (Delaware)
|
$415.36
|
$315.45B | 31.4 | 50 | Compare |
|
AZN
AstraZeneca PLC
|
$157.97
|
$261.56B | 25.4 | 56 | Compare |
|
NVS
Novartis AG
|
$153.67
|
$254.99B | 23.6 | 56 | Compare |
|
MRK
Merck & Co., Inc.
|
$127.77
|
$225.13B | 36.7 | 56 | Compare |
|
AMGN
Amgen Inc
|
$378.87
|
$160.70B | 26.8 | 56 | Compare |
|
PFE
Pfizer Inc.
|
$25.03
|
$154.70B | 19.1 | 56 | Compare |
|
GILD
Gilead Sciences Inc
|
$131.15
|
$137.92B | 17.7 | 54 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$42.95
|
$121.27B | 19.9 | 46 | Compare |
|
BMY
Bristol-Myers Squibb Co.
|
$65.47
|
$96.54B | 14.4 | 51 | Compare |
|
GSK
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
|
$51.51
|
$91.59B | 16.4 | 49 | Compare |
More NVO Analysis
Data updated: Aug 04, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
20 stocks in this industry